Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
- |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
0 |
Cash Flow (TTM) (Millions $) |
11 |
Capital Exp. (TTM) (Millions $) |
0 |
Tg Therapeutics, Inc.
TG Therapeutics, Inc. is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for the treatment of various cancers and autoimmune diseases. The company is committed to discovering novel drugs that can improve the lives of patients with unmet medical needs. TG Therapeutics has a strong pipeline of investigational drugs, including targeted treatments and combination therapies. With a dedicated team of scientists and researchers, the company aims to advance the field of oncology and immunotherapy, ultimately making a positive impact on patient outcomes.
|